Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon. (2021)

First Author: Finney LJ
Attributed to:  MRC Centre for Molecular Bacteriology and Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2020.09.034

PubMed Identifier: 33068560

Publication URI: http://europepmc.org/abstract/MED/33068560

Type: Journal Article/Review

Volume: 147

Parent Publication: The Journal of allergy and clinical immunology

Issue: 2

ISSN: 0091-6749